|
2024
|
P/S
|
promoting public awareness of medical disorders and their treatment; promoting public awareness o... |
|
|
P/S
|
Financial administration of patient financial assistance programs for eligible patients.
Providin... |
|
|
P/S
|
Financial administration of patient financial assistance
programs for eligible patients. Providi... |
|
|
P/S
|
Promoting collaboration within the scientific, research and provider communities to achieve advan... |
|
|
P/S
|
Promoting collaboration within the scientific, research and
provider communities to achieve adva... |
|
|
Invention
|
Crystalline solids of 3-palmitoyl-amido-1,2-propanediol and 3-palmitoyl-amido-2-hydroxy-1-dimetho... |
|
|
P/S
|
Financial administration in the nature of patient financial assistance programs for eligible pati... |
|
|
Invention
|
Telomerase inhibitor compounds.
Provided are telomerase inhibitor compounds. Some compounds incl... |
|
|
Invention
|
Telomerase inhibitor compounds. Provided are telomerase inhibitor compounds. Some compounds inclu... |
|
|
Invention
|
Process for preparing imetelstat.
The present invention relates to a process for preparing the t... |
|
|
Invention
|
Oligonucleotide compositions and methods of making the same.
The present disclosure provides a s... |
|
2023
|
Invention
|
Methods of treating myelodysplastic syndrome and monitoring the treatment.
Methods of monitoring... |
|
|
Invention
|
Methods of treating myelodysplastic syndrome and monitoring the treatment. Methods of monitoring ... |
|
|
P/S
|
Pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and cond... |
|
|
P/S
|
Pharmaceuticals for the treatment, diagnosis or prophylaxis
of human diseases, disorders and con... |
|
|
Invention
|
Method for identification of sensitivity of a patient to telomerase inhibition therapy.
The inve... |
|
|
Invention
|
Synthesis of protected 3'-amino nucleoside monomers.
Orthogonally protected 3′-amino nucleoside ... |
|
|
P/S
|
pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and cond... |
|
2022
|
Invention
|
Amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1- (protected hydroxy)-propane salts ... |
|
|
Invention
|
Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloprolifera... |
|
|
P/S
|
Therapeutic, diagnostic, and prophylactic preparations, pharmaceutical products and agents for th... |
|
|
P/S
|
Therapeutic, diagnostic, and prophylactic preparations,
pharmaceutical products and agents for t... |
|
|
Invention
|
Oligonucleotide compositions and methods of making the same. The present disclosure provides a so... |
|
|
Invention
|
Guanine analogs as telomerase substrates and telomere length affectors.
This invention relates t... |
|
|
Invention
|
Combination treatment for hematological cancers.
The present invention relates to a combination ... |
|
2021
|
P/S
|
Pharmaceuticals. |
|
|
Invention
|
Subcutaneous telomerase inhibitor compositions and methods for using same.
Aspects of the disclo... |
|
|
Invention
|
Subcutaneous telomerase inhibitor compositions and methods for using same. Aspects of the disclos... |
|
2020
|
Invention
|
Use of a janus kinase inhibitor and a telomerase inhibitor for the treatment of myeloproliferativ... |
|
|
Invention
|
Amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1 -(protected hydroxy)-propane salts ... |
|
|
Invention
|
Amorphous solid succinylated 3-(fatty acid amido)-2-hydroxy-1-(protected hydroxy)-propane salts a... |
|
|
Invention
|
Methods of polynucleotide preparation using multivalent cation salt compositions. Aspects of the ... |
|
|
Invention
|
Guanine analogs as telomerase substrates and telomere length affectors. This invention relates to... |
|
2019
|
Invention
|
Methods of treating myelodysplastic syndrome. Methods of monitoring therapeutic efficacy in a sub... |
|
|
Invention
|
Methods of identifying patients likely to benefit from treatment with a telomerase inhibitor.
Th... |
|
|
Invention
|
Methods of identifying patients likely to benefit from treatment with a telomerase inhibitor. Thi... |
|
|
Invention
|
Methods of identifying patients likely to benefit from treatment with a telomerase inhibitor. e.g... |
|
2018
|
Invention
|
Methods of treating myelodysplastic syndrome. This disclosure provides methods of treating a myel... |
|
|
Invention
|
Process for preparing imetelstat. The present invention relates to a process for preparing the te... |
|
|
Invention
|
Improved process for preparing imetelstat. The present invention relates to a process for prepari... |
|
|
Invention
|
Synthesis of protected 3′-amino nucleoside monomers. Orthogonally protected 3′-amino nucleoside m... |
|
2016
|
P/S
|
Chemicals for performing enzymatic and chemi-enzymatic reactions in the field of pharmaceuticals;... |
|
2002
|
P/S
|
THERAPEUTIC, DIAGNOSTIC, AND PROPHYLACTIC PREPARATIONS, PHARMACEUTICAL PRODUCTS AND AGENTS FOR TH... |
|
1998
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use... |
